Abionyx Pharma SA (ABNX)
Euronext
1.62
-0.09 (-5.04%)
Closed
Oct 2, 2026
Day's Range
1.611.67
52 wk Range
1.615.29
Financial Statements - ABNX - Abionyx Pharma SA
Revenue
4.06M▼ 10.7%
Net Income
-5.55M▼ 26.7%Net Margin -136.6%
EBITDA
-5.18M▼ 27.6%
Free Cash Flow
-3.17M▲ 14.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.06M | 4.55M | 4.64M | 5.25M | 675K | 0 |
| Cost of Goods | 3.52M | 3.70M | 4.02M | 4.61M | 416K | 0 |
| Gross Profit | 534K | 844K | 618K | 636K | 259K | 0 |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -5.42M | -4.32M | -3.16M | -3.97M | -5.86M | -2.88M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -5.54M | -4.38M | -3.51M | -4.20M | -5.82M | -1.88M |
| Income Tax | 9K | 0 | 0 | 0 | 0 | 0 |
| Net Income | -5.55M | -4.38M | -3.51M | -4.20M | -5.82M | -1.88M |
| EPS Basic | -0.16 | -0.12517 | -0.107077 | -0.15 | -0.23 | -0.08 |
| EPS Diluted | -0.16 | -0.12517 | -0.107077 | -0.15 | -0.23 | -0.08 |
| Basic Shares Outstanding | 34.95M | 35.15M | 32.68M | 27.96M | 24.87M | 22.50M |
| Diluted Shares Outstanding | 34.95M | 35.15M | 32.68M | 27.96M | 24.87M | 22.50M |
| Ebit | -5.45M | -4.34M | -3.49M | -4.14M | -5.81M | -1.88M |
| Ebitda | -5.18M | -4.06M | -3.09M | -3.87M | -5.61M | -1.77M |
| Net Income Continuous Operations | -5.55M | -4.38M | -3.51M | -4.20M | -5.82M | -1.88M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
